AAAAAA
Results:
1-8
|
Results: 8
Authors:
Hirsh, V
Langleben, A
Ayoub, J
Cormier, Y
Pintos, J
Iglesias, JL
Citation: V. Hirsh et al., Flexible chemotherapy regimen with gemcitabine and vinorelbine for metastatic nonsmall cell lung carcinoma - A phase II multicenter trial, CANCER, 92(4), 2001, pp. 830-835
Authors:
Muanza, T
Shenouda, G
Souhami, L
Leblanc, R
Mohr, G
Corns, R
Langleben, A
Citation: T. Muanza et al., High dose tamoxifen and radiotherapy in patients with glioblastoma multiforme: A phase IB study, CAN J NEUR, 27(4), 2000, pp. 302-306
Authors:
Preul, MC
Caramanos, Z
Villemure, JG
Shenouda, G
LeBlanc, R
Langleben, A
Arnold, DL
Citation: Mc. Preul et al., Using proton magnetic resonance spectroscopic imaging to predict in vivo the response of recurrent malignant gliomas to tamoxifen chemotherapy, NEUROSURGER, 46(2), 2000, pp. 306-318
Authors:
Lachaine, J
Laurier, C
Langleben, A
Vaillant, L
Citation: J. Lachaine et al., Cost-effectiveness and quality of life evaluation of ondansetron and metoclopramide for moderately emetogenic chemotherapy regimens in breast cancer, CR R ONC H, 32(2), 1999, pp. 105-112
Authors:
Murray, N
Livingston, RB
Shepherd, FA
James, K
Zee, B
Langleben, A
Kraut, M
Bearden, J
Goodwin, JW
Grafton, C
Turrisi, A
Walde, D
Croft, H
Osoba, D
Ottaway, J
Gandara, D
Citation: N. Murray et al., Randomized study of CODE versus alternating CAV/EP for extensive-stage small-cell lung cancer: An intergroup study of the National Cancer Institute of Canada Clinical Trials Group and the Southwest Oncology Group, J CL ONCOL, 17(8), 1999, pp. 2300-2308
Authors:
Chen, ZP
Yarosh, D
Garcia, Y
Tampieri, D
Mohr, G
Malapetsa, A
Langleben, A
Panasci, LC
Citation: Zp. Chen et al., Relationship between O-6-methylguanine-DNA methyltransferase levels and clinical response induced by chloroethylnitrosourea therapy in glioma patients, CAN J NEUR, 26(2), 1999, pp. 104-109
Authors:
Rosemurgy, A
Harris, J
Langleben, A
Casper, E
Goode, S
Rasmussen, H
Citation: A. Rosemurgy et al., Marimastat in patients with advanced pancreatic cancer - A dose-finding study, AM J CL ONC, 22(3), 1999, pp. 247-252
Authors:
Viallet, J
Brassard, MA
Souhami, L
Ayoub, J
Del Vecchio, P
Kreisman, H
Guerra, J
Gruber, J
Langleben, A
Hohneker, J
Rousseau, P
Citation: J. Viallet et al., A phase I II trial of neoadjuvant chemotherapy with cisplatin and vinorelbine followed by accelerated irradiation for patients with inoperable nonsmall cell lung carcinoma, CANCER, 85(12), 1999, pp. 2562-2569
Risultati:
1-8
|